Answer all questions/criteria with explanations and detail. 1. Briefly summarize the condition you selected DIABETES MELLITIS and your rationale(amount of US affected by DM is the rationale) for selecting it. 2. Describe the prescribing recommendations from the CPG (ATTACHED-PLEASE REFERENCE) and how these could impact pediatric, pregnant, and older adult populations considering pharmacokinetic principles. 3. Discuss how you could apply the clinical guidelines to your future practice. 4.In considering the summary from this article(ATTACHED)., review the strengths and weaknesses of the CPG you selected and discuss how the graded evidence may influence your practice as a clinician.